Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints
MKB Parmar, V Torri, L Stewart - Statistics in medicine, 1998 - Wiley Online Library
Meta‐analyses aim to provide a full and comprehensive summary of related studies which
have addressed a similar question. When the studies involve time to event (survival‐type) …
have addressed a similar question. When the studies involve time to event (survival‐type) …
[HTML][HTML] Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
…, LC Brown, R Gabe, R Kaplan, MK Parmar… - The Lancet, 2017 - thelancet.com
Background Men with high serum prostate specific antigen usually undergo transrectal
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including …
ultrasound-guided prostate biopsy (TRUS-biopsy). TRUS-biopsy can cause side-effects including …
[HTML][HTML] A phase 3 trial of bevacizumab in ovarian cancer
…, M Plante, D Stark, W Qian, MKB Parmar… - … England Journal of …, 2011 - Mass Medical Soc
Background Angiogenesis plays a role in the biology of ovarian cancer. We examined the
effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women …
effect of bevacizumab, the vascular endothelial growth factor inhibitor, on survival in women …
[HTML][HTML] Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive …
…, S Sundar, S Tolan, D Tsang, J Wagstaff, MKB Parmar - The Lancet, 2016 - thelancet.com
Background Long-term hormone therapy has been the standard of care for advanced prostate
cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, …
cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, …
[HTML][HTML] Abiraterone for prostate cancer not previously treated with hormone therapy
…, J Wylie, A Zarkar, MKB Parmar… - … England Journal of …, 2017 - Mass Medical Soc
Background Abiraterone acetate plus prednisolone improves survival in men with relapsed
prostate cancer. We assessed the effect of this combination in men starting long-term …
prostate cancer. We assessed the effect of this combination in men starting long-term …
[HTML][HTML] Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre …
…, E Bessell, G Griffiths, LC Thompson, M Parmar - The Lancet, 2009 - thelancet.com
Background Preoperative or postoperative radiotherapy reduces the risk of local recurrence
in patients with operable rectal cancer. However, improvements in surgery and …
in patients with operable rectal cancer. However, improvements in surgery and …
Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of …
P Royston, MKB Parmar - Statistics in medicine, 2002 - Wiley Online Library
Modelling of censored survival data is almost always done by Cox proportional‐hazards
regression. However, use of parametric models for such data may have some advantages. For …
regression. However, use of parametric models for such data may have some advantages. For …
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
…, J Twigg, J Herod, G McCluggage, M Parmar… - The Lancet, 2015 - thelancet.com
Background The international standard of care for women with suspected advanced ovarian
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
[BOOK][B] Survival analysis: a practical approach
D Machin, YB Cheung, M Parmar - 2006 - books.google.com
Well received in its first edition, Survival Analysis: A Practical Approach is completely revised
to provide an accessible and practical guide to survival analysis techniques in diverse …
to provide an accessible and practical guide to survival analysis techniques in diverse …
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
…, RJ Stephens, I Syndikus, MKB Parmar - The lancet …, 2007 - thelancet.com
Background In men with localised prostate cancer, conformal radiotherapy (CFRT) could
deliver higher doses of radiation than does standard-dose conventional radical external-beam …
deliver higher doses of radiation than does standard-dose conventional radical external-beam …